| Date | Form | Description | Docs | XBRL | Pages |
| 05/27/21 | 8-K | Current report filing |
|
9 | |
| 05/04/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/23/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/20/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/20/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/09/21 | DEF 14A | Definitive proxy statements |
|
21 | |
| 04/02/21 | 8-K | Current report filing |
|
3 | |
| 03/30/21 | PRE 14A | Preliminary proxy statement not related to a contested matter or merger/acquisition |
|
22 | |
| 03/26/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/26/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10
Read More...Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset
Read More...Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial
Read More...